• Consensus Rating: Hold
  • Consensus Price Target: $20.04
  • Forecasted Upside: 3.04%
  • Number of Analysts: 8
  • Breakdown:
  • 1 Sell Ratings
  • 3 Hold Ratings
  • 4 Buy Ratings
  • 0 Strong Buy Ratings
$19.45
▼ -0.18 (-0.92%)

This chart shows the closing price for CLMT by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Calumet Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for CLMT and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for CLMT

Analyst Price Target is $20.04
▲ +3.04% Upside Potential
This price target is based on 8 analysts offering 12 month price targets for Calumet in the last 3 months. The average price target is $20.04, with a high forecast of $33.00 and a low forecast of $13.25. The average price target represents a 3.04% upside from the last price of $19.45.

This chart shows the closing price for CLMT for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Hold

The current consensus among 8 investment analysts is to hold stock in Calumet. This rating has held steady since September 2025, when it changed from a Moderate Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/12/2024
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/10/2024
  • 0 strong buy ratings
  • 4 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/9/2024
  • 0 strong buy ratings
  • 3 buy ratings
  • 1 hold ratings
  • 1 sell ratings
3/9/2025
  • 0 strong buy ratings
  • 4 buy ratings
  • 2 hold ratings
  • 0 sell ratings
6/7/2025
  • 0 strong buy ratings
  • 4 buy ratings
  • 2 hold ratings
  • 0 sell ratings
9/5/2025
  • 0 strong buy ratings
  • 4 buy ratings
  • 2 hold ratings
  • 2 sell ratings
11/4/2025
  • 0 strong buy ratings
  • 4 buy ratings
  • 3 hold ratings
  • 1 sell ratings
12/4/2025

Latest Recommendations

  • 0 strong buy ratings
  • 4 buy ratings
  • 3 hold ratings
  • 1 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
12/1/2025Weiss RatingsReiterated RatingSell (D-) ➝ Sell (D-)
11/24/2025Weiss RatingsReiterated RatingSell (D-) ➝ Sell (D-)
11/17/2025Weiss RatingsReiterated RatingSell (D-) ➝ Sell (D-)
11/11/2025TD CowenBoost TargetHold$15.00 ➝ $18.00
11/10/2025HC WainwrightReiterated RatingBuy ➝ Buy$33.00
11/6/2025Zacks ResearchUpgradeStrong Sell ➝ Hold
10/22/2025The Goldman Sachs GroupBoost TargetBuy ➝ Buy$15.00 ➝ $20.00
10/8/2025Weiss RatingsReiterated RatingSell (E+) ➝ Sell (E+)
10/7/2025Zacks ResearchDowngradeHold ➝ Strong Sell
9/27/2025Weiss RatingsReiterated RatingSell (E+) ➝ Sell (E+)
8/12/2025UBS GroupBoost TargetNeutral ➝ Neutral$12.00 ➝ $13.25
5/14/2025Wells Fargo & CompanyLower TargetOverweight ➝ Overweight$23.00 ➝ $21.00
5/13/2025Bank of AmericaInitiated CoverageBuy$15.00
4/30/2025The Goldman Sachs GroupLower TargetBuy ➝ Buy$16.00 ➝ $14.00
4/9/2025Wells Fargo & CompanyLower TargetOverweight ➝ Overweight$28.00 ➝ $23.00
3/17/2025UBS GroupUpgradeSell ➝ Neutral$15.00 ➝ $12.00
3/5/2025Wells Fargo & CompanyLower TargetOverweight ➝ Overweight$29.00 ➝ $28.00
3/4/2025TD CowenDowngradeBuy ➝ Hold$26.00 ➝ $16.00
3/3/2025HC WainwrightReiterated RatingBuy ➝ Buy$33.00 ➝ $33.00
2/12/2025HC WainwrightReiterated RatingBuy ➝ Buy$33.00 ➝ $33.00
2/4/2025UBS GroupDowngradeNeutral ➝ Sell$20.50 ➝ $15.00
1/13/2025HC WainwrightBoost TargetBuy ➝ Buy$25.00 ➝ $33.00
11/11/2024TD CowenLower TargetBuy ➝ Buy$27.00 ➝ $26.00
11/11/2024HC WainwrightReiterated RatingBuy ➝ Buy$25.00 ➝ $25.00
10/21/2024Wells Fargo & CompanyBoost TargetOverweight ➝ Overweight$25.00 ➝ $29.00
10/17/2024HC WainwrightReiterated RatingBuy ➝ Buy$25.00 ➝ $25.00
10/17/2024TD CowenBoost TargetBuy ➝ Buy$22.00 ➝ $27.00
10/7/2024HC WainwrightReiterated RatingBuy ➝ Buy$25.00 ➝ $25.00
8/12/2024HC WainwrightReiterated RatingBuy ➝ Buy$25.00 ➝ $25.00
8/12/2024TD CowenLower TargetBuy ➝ Buy$20.00 ➝ $18.00
8/5/2024The Goldman Sachs GroupLower TargetBuy ➝ Buy$17.00 ➝ $15.00
5/13/2024HC WainwrightReiterated RatingBuy ➝ Buy$25.00
4/22/2024HC WainwrightReiterated RatingBuy ➝ Buy$25.00
3/21/2024The Goldman Sachs GroupLower TargetBuy ➝ Buy$19.00 ➝ $17.00
12/14/2023The Goldman Sachs GroupBoost TargetBuy ➝ Buy$17.00 ➝ $19.00
10/31/2023The Goldman Sachs GroupLower TargetBuy ➝ Buy$19.00 ➝ $17.00
8/7/2023HC WainwrightReiterated RatingBuy ➝ Buy$25.00
5/15/2023UBS GroupBoost Target$18.50 ➝ $19.50
1/25/2023HC WainwrightLower TargetBuy$28.00 ➝ $25.00
12/13/2022UBS GroupInitiated CoverageNeutral$15.70
8/18/2022The Goldman Sachs GroupUpgradeNeutral ➝ Buy$14.00 ➝ $23.00
6/28/2022CowenBoost TargetOutperform$18.00 ➝ $20.00
5/9/2022CowenBoost Target$18.00 ➝ $20.00
4/21/2022Wells Fargo & CompanyBoost TargetOverweight$27.00 ➝ $29.00
2/28/2022CowenLower TargetOutperform$23.00 ➝ $20.00
2/28/2022HC WainwrightBoost TargetBuy$19.00 ➝ $28.00
1/6/2022Credit Suisse GroupInitiated CoverageNeutral$23.00
11/23/2021Wolfe ResearchUpgradePeer Perform ➝ Outperform$30.00
11/23/2021CowenUpgradeMarket Perform ➝ Outperform$12.00 ➝ $23.00
11/22/2021Wells Fargo & CompanyBoost TargetOverweight$14.00 ➝ $27.00
10/14/2021The Goldman Sachs GroupBoost TargetNeutral$6.00 ➝ $11.00
10/8/2021Wells Fargo & CompanyBoost TargetOverweight$8.00 ➝ $11.00
10/5/2021Wells Fargo & CompanyReiterated RatingOverweight ➝ Market Perform$8.00
10/4/2021HC WainwrightInitiated CoverageBuy$19.00
3/24/2021Wells Fargo & CompanyUpgradeEqual Weight ➝ Overweight$8.00
12/15/2020Wells Fargo & CompanyDowngradeOverweight ➝ Equal Weight$4.00
(Data available from 12/4/2020 forward)

News Sentiment Rating

0.76 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 2 very positive mentions
  • 11 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/8/2025
  • 3 very positive mentions
  • 11 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
6/7/2025
  • 6 very positive mentions
  • 7 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
7/7/2025
  • 3 very positive mentions
  • 7 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
8/6/2025
  • 4 very positive mentions
  • 11 positive mentions
  • 1 negative mentions
  • 2 very negative mentions
9/5/2025
  • 6 very positive mentions
  • 6 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
10/5/2025
  • 2 very positive mentions
  • 11 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
11/4/2025
  • 16 very positive mentions
  • 18 positive mentions
  • 3 negative mentions
  • 0 very negative mentions
12/4/2025

Current Sentiment

  • 16 very positive mentions
  • 18 positive mentions
  • 3 negative mentions
  • 0 very negative mentions
Calumet logo
Calumet, Inc. engages in the manufacturing, formulating, and marketing of a diversified slate of specialty branded products and renewable fuels to customers across a broad range of consumer-facing and industrial markets. It operates through the following segments: Specialty Products & Solutions, Performance Brands, Montana/Renewables, and Corporate. The Specialty Products & Solutions segment consists of customer-focused solutions and formulations businesses, covering multiple specialty product lines, anchored by a unique integrated complex in Northwest Louisiana. The Performance Brands segment includes a fast-growing portfolio of high-quality, high performing brands. The Montana/Renewables segment is composed of a Great Falls specialty asphalt facility and Montana Renewables facility. The Corporate segment focuses on the general and administrative expenses not allocated to the Montana/Renewables, Specialty Products and Solutions, or Performance Brands segments. The company was founded in 1919 and is headquartered in Indianapolis, IN.
Read More

Today's Range

Now: $19.45
Low: $19.42
High: $19.75

50 Day Range

MA: $18.98
Low: $17.68
High: $20.11

52 Week Range

Now: $19.45
Low: $7.68
High: $23.75

Volume

413,317 shs

Average Volume

735,469 shs

Market Capitalization

$1.69 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.18

Frequently Asked Questions

What sell-side analysts currently cover shares of Calumet?

The following Wall Street analysts have issued research reports on Calumet in the last twelve months: Bank of America Corporation, HC Wainwright, TD Cowen, The Goldman Sachs Group, Inc., UBS Group AG, Wall Street Zen, Weiss Ratings, Wells Fargo & Company, and Zacks Research.
View the latest analyst ratings for CLMT.

What is the current price target for Calumet?

0 Wall Street analysts have set twelve-month price targets for Calumet in the last year. Their average twelve-month price target is $20.04, suggesting a possible upside of 3.0%. HC Wainwright has the highest price target set, predicting CLMT will reach $33.00 in the next twelve months. UBS Group AG has the lowest price target set, forecasting a price of $13.25 for Calumet in the next year.
View the latest price targets for CLMT.

What is the current consensus analyst rating for Calumet?

Calumet currently has 1 sell rating, 3 hold ratings and 4 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in CLMT, but not buy more shares or sell existing shares.
View the latest ratings for CLMT.

What other companies compete with Calumet?

How do I contact Calumet's investor relations team?

Calumet's physical mailing address is 2780 WATERFRONT PARKWAY EAST DRIVE SUITE 200, INDIANAPOLIS IN, 46214. The oil and gas company's listed phone number is (317) 328-5660 and its investor relations email address is [email protected]. The official website for Calumet is www.calumetspecialty.com. Learn More about contacing Calumet investor relations.